About
Christian Schubert is a hybrid operator-investor who shapes corporate venture strategy across US, Europe and Asia‑Pacific, pairing genetics, neurobiology and biochemistry training with large‑pharma experience and active biotech board involvement.
Contact· self-published, not guessed
Invests in
AI & Machine LearningBiotechData & InfrastructureHealthtech
Experience
- AbbVieVice President and Global Head, AbbVie Venturescurrent2022 — presentCambridge, MA
- Mozart Therapeutics, IncMember | Board of Directorscurrent2023 — presentSeattle, Washington, United States
- Zag BioMember | Board of Directorscurrent2023 — presentCambridge, Massachusetts, United States
- DISCO Pharmaceuticals GmbHMember | Board of Directorscurrent2023 — presentCologne, North Rhine-Westphalia, Germany
- ReAx BiotechnologiesMember | Board of Directorscurrent2023 — presentChicago, Illinois, United States
- Dimericon TherapeuticsMember | Board of Directorscurrent2023 — presentZurich, Switzerland
- Soufflé TherapeuticsObserver | Board of Directorscurrent2024 — presentWatertown, Massachusetts, United States
- Umoja BiopharmaObserver | Board of Directorscurrent2023 — presentSeattle, WA
- Aquinnah PharmaceuticalsObserver | Board of Directorscurrent2023 — presentCambridge, Massachusetts, United States
- Blackbird LaboratoriesAdvisory Board Membercurrent2025 — present
- Alexandria LaunchLabsAdvisor | Seed Capital Platformcurrent2023 — present
- Bakar Bio LabsAdvisor | Bakar Bio Labscurrent2023 — present
- DG MedicinesObserver | Board of Directors2023 — 2025Boston, Massachusetts, United States
- Enthera PharmaceuticalsMember | Board of Directors2023 — 2024Milan, Lombardy, Italy
- Enthera PharmaceuticalsObserver | Board of Directors2023Milan, Lombardy, Italy
- Ribometrix Inc.Member | Board of Directors2023 — 2024Durham, North Carolina, United States
- Portera TherapeuticsMember | Board of Directors2023 — 2024East Lansing, Michigan, United States
- Ambagon TherapeuticsMember | Board of Directors2023 — 2024San Francisco, California, United States
- SNC Therapeutics, Inc.Member | Board of Directors2023 — 2024Chicago, Illinois, United States
- Ribon TherapeuticsObserver | Board of Directors2023 — 2024Cambridge, Massachusetts, United States
- Accent Therapeutics, Inc.Observer | Board of Directors2023 — 2024Lexington, Massachusetts, United States
- Quanta TherapeuticsObserver | Board of Directors2023 — 2024San Francisco, California, United States
- Kojin TherapeuticsObserver | Board of Directors2023 — 2024Boston, Massachusetts, United States
- Caraway Therapeutics, Inc.Member | Board of Directors2023Cambridge, Massachusetts, United States
- Atlas VentureCo-Founder and Advisor, Modify Therapeutics2022Cambridge, Massachusetts, United States
- Atlas VentureCo-Founder and President, Modify Therapeutics2022Cambridge, MA
- Atlas VentureEntrepreneur In Residence (EIR)2021 — 2022Cambridge, Massachusetts, United States
- Korro Bio, Inc.Advisor | CNS Biology, Neuroscience Strategy and Operations2021 — 2022Cambridge, Massachusetts, United States
- ServierGlobal Head, External Innovation | Research and Development2018 — 2021Paris Area, France
- ServierManaging Director | Servier BioInnovation2018 — 2021Cambridge, Massachusetts, United States
- BioMotivAdvisory Board Member2016 — 2019Cleveland, Ohio
- Israel Biotech FundStrategic Advisor2016 — 2018Rehovot, Israel
- BiogenDirector | Corporate Strategy, Business Development and External Innovation2015 — 2018Cambridge, Massachusetts
- Harvard UniversityHead Teaching Fellow | MCB 80 - Neurobiology of Behavior2010 — 2017Cambridge, Massachusetts
- Harvard UniversitySenior Teaching Fellow | Life Sciences 1b - Genetics, Genomics and Evolution2011 — 2016Cambridge, Massachusetts
- Harvard UniversityHead Writer and Content Developer | HarvardX | Fundamentals of Neuroscience (mcb80x)2013 — 2015Cambridge, Massachusetts
- PfizerAssociate Director | Precision Medicine, Human Genetics and Computational Biomedicine2012 — 2015Cambridge, Massachusetts
- Broad Institute of MIT and HarvardVisiting Postdoctoral Scholar | Medical and Population Genetics2010 — 2014Cambridge, Massachusetts
- Boston Children's HospitalRuth L. Kirschstein NIH Postdoctoral Research Fellow | Pediatrics2010 — 2013Boston, Massachusetts
- Massachusetts Institute of TechnologyVisiting Scholar and Research Affiliate | Research Laboratory of Electronics2009 — 2012Cambridge, Massachusetts
Skills & more
Neuroscience14Drug Discovery21Biochemistry19Life Sciences12Biotechnology9Genetics25Molecular Biology1Genomics2Clinical Development6ResearchClinical Trials1Confocal Microscopy1
+2 more
Cell BiologyClinical ResearchLanguages English · French · German · Swedish
From Christian's professional profile.
Colleagues at AbbVie
Anke Reichardt
Investor at AbbVie
Azurii Collier
Commercial Advisor at 2Flo Ventures
Christina Vorvis
Director at AbbVie
Claire Leurent
Managing Director at AbbVie
Donmienne Leung
Director II, Head of AbbVie Ventures Europe at AbbVie
Doug Faunce
Executive Director at AbbVie
Joachim Vogt
Director at AbbVie
John Ballew
Senior Associate at JDRF T1D Fund
Frequently asked questions
- Who is Christian Schubert?
- Christian Schubert is a hybrid operator-investor who shapes corporate venture strategy across US, Europe and Asia‑Pacific, pairing genetics, neurobiology and biochemistry training with large‑pharma experience and active biotech board involvement.
- Where does Christian Schubert work?
- Christian Schubert is Head of AbbVie Ventures at AbbVie.
- What does Christian Schubert invest in?
- Christian Schubert invests in AI & Machine Learning, Biotech, Data & Infrastructure, Healthtech.
- Where did Christian Schubert go to school?
- Christian Schubert studied at Harvard Medical School (Postdoctoral Fellowship (Boston Children's Hospital), Neuroscience); Massachusetts Institute of Technology (Doctor of Philosophy (Ph.D.), Biological Chemistry); Harvard University (Certificate, Introduction to Clinical Investigation).
Same school
Also attended Harvard Medical School190
Niko BonatsosVerdict Capital founder and pre-consensus investor formerly at General CatalystAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital
.png)
+ 184 more
Also attended Massachusetts Institute of Technology1,720
Fred WilsonCo-founder & Partner at Union Square VenturesElad GilSolo general partner investing through Gil CapitalAileen LeeFounder & Managing Partner of Cowboy VenturesHemant TanejaCEO & Managing Director of General CatalystPhilippe LaffontFounder & CIO of Coatue ManagementNat FriedmanCo-lead of Meta Superintelligence Labs; co-founder of NFDG
+ 1,714 more
Also attended Harvard University1,941
Ron ConwayFounder of SV AngelAlfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalG
+ 1,935 more
Also attended Technical University of Munich355
Julian von EckartsbergManaging Director Europe at Burda Principal InvestmentsHannes Voucko-GlocknerInvestment Analyst at Burda Principal InvestmentsPaula SchultheissSenior Associate at AN Venture PartnersThomas MeierPartner, Head of Resilience in Energy & Resources Investments at Verve VenturesNiklas Born de AndrésInvestment & Product Intern at Kibo VenturesItziar EstevezPartner - Growth at Iris Capital
+ 349 more
